To generate superior risk adjusted returns with our Growth At Reasonable Price style of investing.
| Alpha (1Y) | Beta (1Y) | Standard Deviation (1Y) | % of +ve Months (SI) |
|---|---|---|---|
| -12.34% | 1.03 | 20.76% | 66.17% |
Performance Table #
| Trailing Returns (%) | 1m return | 3m return | 6m return | 1y return | 2y return | 3y return | 5y return | 10y return | Since inception return |
|---|---|---|---|---|---|---|---|---|---|
| Portfolio | -3.40% | 1.40% | 15.40% | 0.50% | 30.00% | 30.00% | 11.20% | 28.10% | 26.30% |
| BSE Midcap | -2.50% | 1.90% | 16.60% | 1.40% | 18.80% | 19.10% | 7.30% | 13.50% | 13.60% |
QRC Report Card *
| Strategy | Category | Fund Manager | Date of Inception | Age Of PMS | Corpus (in Cr, approx) | Benchmark | Returns SI (CAGR) | Stocks In Portfolio | Sectors In Portfolio |
|---|---|---|---|---|---|---|---|---|---|
| Master Portfolio MPSL Vallum India Discovery | Mid & Small Cap | Investment Committee | 22 October 2011 | 11Y 3M | 510.58 | BSE Midcap | 26.30% | 21 | 9 |
| Portfolio Quality (Q) | Portfolio Risk (R) | Portfolio Consistency (C) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Index | Category Alpha (1Y) | Relative Alpha (1Y) |
% of +ve Months
(Fund Data) |
Alpha (1Y) | Beta (1Y) |
Standard Deviation (1Y)
(Fund Data) |
Sharpe Ratio (1Y)
(Fund Data) |
Alpha (SI) | Information Ratio (SI) | Consistency Ratio % |
| Nifty 50 | 3.71% | -12.15% | 66.17% | -8.44% | 1.37 | 20.76% | -0.73 | 14.57% | 1.00 | 63.16 % |
| Nifty 500 | 1.29% | -11.21% | -9.92% | 1.30 | 13.63% | 1.07 | 61.65 % | |||
| Nifty Midcap 100 | -5.50% | -6.84% | -12.34% | 1.03 | 11.74% | 1.03 | 59.40 % | |||
| Nifty Smallcap 100 | 1.22% | 2.03% | 3.25% | 0.88 | 16.43% | 1.29 | 60.90 % | |||
VIEW DETAILED QUALITY, RISK, CONSISTENCY ANALYSIS
Portfolio Holdings
| Holding | % |
|---|
Sector Allocation
| Holding | % |
|---|---|
| Sugar | 4.57 |
| Telecommunication | 4.57 |
| Exchange | 6.04 |
| Information Technology | 9.90 |
| Chemicals | 11.36 |
| Consumer Products | 11.64 |
| Financials | 15.54 |
| Pharmaceuticals & Biotechnology | 18.11 |
| Materials | 18.27 |
Market Cap Allocation
| Allocations | % |
|---|---|
| Large Cap | 34.40 |
| Mid Cap | 42.50 |
| Small Cap | 19.40 |
| Cash | 3.70 |
Do Not Simply Invest, Make Informed Decisions
WISH TO MAKE INFORMED INVESTMENTS FOR LONG TERM WEALTH CREATION
Book
a call with our PMS AIF Specialists
Disclaimer
#Returns as of 31 Dec 2022. Returns up to 1 Year are absolute, above 1 Year are CAGR.
*QRC Report Card data is updated quarterly. Current data is as of Sep 22.
